1-aminobenzotriazole has been researched along with Disease Models, Animal in 9 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1 The purpose of this study was to examine the effect of inhibition of the formation of cytochrome P450 metabolites of arachidonic acid with 1-aminobenzotriazole (ABT) on the development of hypertension and end-organ damage in spontaneously hypertensive rats (SHR) chronically treated with nitric oxide synthesis inhibitor L-NAME (SHR-L-NAME)." | 7.73 | Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. ( Benter, IF; Canatan, H; Cojocel, C; Francis, I; Juggi, JS; Yousif, MH, 2005) |
| "1 The purpose of this study was to examine the effect of inhibition of the formation of cytochrome P450 metabolites of arachidonic acid with 1-aminobenzotriazole (ABT) on the development of hypertension and end-organ damage in spontaneously hypertensive rats (SHR) chronically treated with nitric oxide synthesis inhibitor L-NAME (SHR-L-NAME)." | 3.73 | Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. ( Benter, IF; Canatan, H; Cojocel, C; Francis, I; Juggi, JS; Yousif, MH, 2005) |
| " Non-compartmental pharmacokinetic analysis was performed using PKsolver." | 1.46 | Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model. ( Abla, N; Haas, H; Keiser, J; Reimers, N; Spangenberg, T; Vargas, M, 2017) |
| " Administration of radio-labeled TIC in combination with BSO resulted in significantly higher covalent binding to rat liver proteins than that observed after sole dosing of radio-labeled TIC." | 1.37 | Ticlopidine-induced hepatotoxicity in a GSH-depleted rat model. ( Atsumi, R; Izumi, T; Nakazawa, T; Okazaki, O; Saji, H; Shimizu, S; Sudo, K, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Abla, N | 1 |
| Keiser, J | 1 |
| Vargas, M | 1 |
| Reimers, N | 1 |
| Haas, H | 1 |
| Spangenberg, T | 1 |
| Orozco, LD | 1 |
| Liu, H | 1 |
| Perkins, E | 1 |
| Johnson, DA | 1 |
| Chen, BB | 1 |
| Fan, F | 2 |
| Baker, RC | 1 |
| Roman, RJ | 2 |
| Zong, C | 1 |
| Garner, CE | 1 |
| Huang, C | 1 |
| Zhang, X | 1 |
| Zhang, L | 1 |
| Chang, J | 1 |
| Toyokuni, S | 1 |
| Ito, H | 1 |
| Kato, M | 1 |
| Sakurai, T | 1 |
| Ichihara, S | 1 |
| Ichihara, G | 1 |
| Chen, J | 1 |
| Mannargudi, BM | 1 |
| Xu, L | 1 |
| Uetrecht, J | 1 |
| Shimizu, S | 1 |
| Atsumi, R | 1 |
| Nakazawa, T | 1 |
| Izumi, T | 1 |
| Sudo, K | 1 |
| Okazaki, O | 1 |
| Saji, H | 1 |
| Yanes, LL | 1 |
| Lima, R | 1 |
| Moulana, M | 1 |
| Romero, DG | 1 |
| Yuan, K | 1 |
| Ryan, MJ | 1 |
| Baker, R | 1 |
| Zhang, H | 1 |
| Davis, DD | 1 |
| Reckelhoff, JF | 1 |
| Benter, IF | 1 |
| Francis, I | 1 |
| Cojocel, C | 1 |
| Juggi, JS | 1 |
| Yousif, MH | 1 |
| Canatan, H | 1 |
9 other studies available for 1-aminobenzotriazole and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model.
Topics: Animals; Anthelmintics; Chemoprevention; Chromatography, Liquid; Dexamethasone; Disease Models, Anim | 2017 |
20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries.
Topics: Amidines; Angioplasty, Balloon, Coronary; Animals; Carotid Artery Injuries; Carotid Artery, Common; | 2013 |
Preliminary characterization of a murine model for 1-bromopropane neurotoxicity: Role of cytochrome P450.
Topics: Animals; Atmosphere Exposure Chambers; Cerebral Cortex; Chemical and Drug Induced Liver Injury; Cyto | 2016 |
Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash.
Topics: Animals; Chromatography, Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Exanthema | 2008 |
Ticlopidine-induced hepatotoxicity in a GSH-depleted rat model.
Topics: Animals; Buthionine Sulfoximine; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dru | 2011 |
Postmenopausal hypertension: role of 20-HETE.
Topics: Aging; Animals; Blood Pressure; Cytochrome P-450 CYP4A; Disease Models, Animal; Female; Hydroxyeicos | 2011 |
Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
Topics: Animals; Arachidonic Acid; Blood Pressure; Blood Vessels; Collagen Type III; Coronary Vessels; Cytoc | 2005 |